Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV.H

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV.H)

Avivagen Press Release Correction

Business Wire April 12, 2019

Avivagen Announces Results From Its Annual General Meeting April 10, 2019

Business Wire April 11, 2019

Avivagen Continues Expansion with an Order from a New Market in Asia

Business Wire April 10, 2019

Avivagen Announces Final Closing of Private Placement of Debentures and Shares

Business Wire April 9, 2019

Avivagen to Pursue Business Opportunities for Combining Its Proprietary OxC-beta™ with Cannabis Products

Business Wire April 3, 2019

Avivagen Announces Closing of Private Placement of Debentures and Shares

Business Wire March 28, 2019

Avivagen Announces Proposed Private Placement of Debentures and Shares

Business Wire March 27, 2019

Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2019

GlobeNewswire March 6, 2019

Avivagen Announces Large Order for OxC-beta™ Livestock and Expansion into Additional Applications

GlobeNewswire February 28, 2019

Avivagen enters into Partnership with CSA to Sell and Distribute OxC-beta™ Livestock in the United States

GlobeNewswire February 20, 2019

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2018

GlobeNewswire January 31, 2019

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

GlobeNewswire January 18, 2019

Avivagen Announces CEO Letter to Shareholders

GlobeNewswire January 17, 2019

Avivagen Inc. Announces Change of Auditor

GlobeNewswire January 3, 2019

Avivagen Announces Proposed Extension of Warrants

GlobeNewswire December 20, 2018

Avivagen Announces Clarification to Press Release Issued November 19, 2018

GlobeNewswire November 19, 2018

Avivagen’s Asian partner UNAHCO continues to ramp-up use of OxC-beta™ Livestock with new large order

GlobeNewswire November 19, 2018

World Health Organization’s “World Antibiotic Awareness Week” highlights the need for Avivagen’s products

GlobeNewswire November 15, 2018

Avivagen Announces Distribution Agreement for Vivamune™ in Vietnam

GlobeNewswire October 18, 2018

Avivagen Announces Distribution Agreement for OxC-beta™ Livestock in Malaysia

GlobeNewswire October 11, 2018